Rookie outfielder Carson Benge, making his Mets regular season debut, brought Citi Field to its feet when he blasted a solo ...

Bitdefender finds a sharp rise in phishing and malware emails targeting Gulf countries after February 28 escalation.

Anthropic has updated its Claude Cowork and Claude Code tools to let them autonomously carry out tasks on your PC. Without ...

In 1979, Steve Jobs led a delegation from Apple into Xerox's secretive Silicon Valley computer lab. The world would never be ...

So, you’re wondering which programming language is the absolute hardest to learn in 2026? It’s a question that pops up a lot, especially when you see all the new languages coming out. People often ...

EDMONDS, Wash. — Syreh Sonko is studying nursing at Edmonds College through Washington state's Running Start, but the program that's saving her nearly $30,000 in college costs may soon look different.

Parts of the Running Start college credit program could be cut in Washington due to budget issues. Heavy snow warning as up to 18 inches to strike: 'Hazardous' Chuck Norris dies at 86 Seafood ...

CHARLESTON — A nonprofit run by City Councilman Aaron Polkey, who was sworn in last month, is set to receive nearly $240,000 from the city for a homeless program. Polkey, president and CEO of Palmetto ...

Without a doubt, one of the hottest new startup accelerators in tech right now is Andreessen Horowitz’s Speedrun program. Launched in 2023, the accelerator has an acceptance rate of less than 1%. In a ...

TURKU, Finland, Feb. 10, 2026 /PRNewswire/ -- Vaadin, the leading provider of Java web application frameworks, today announced the general availability of Swing Modernization Toolkit, a solution that ...

Fullerton has launched its new city-operated ambulance transportation program. Under the model, fire personnel will manage the full emergency response, from initial patient contact to transport to a ...

Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.